Healix Recalls Fentanyl Syringes Due to Sterility Concerns
Healix Infusion Therapy is recalling 50 fentanyl syringes because the supplier recalled the drug due to loose or missing vial crimps, raising sterility concerns.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a lack of assurance of sterility in a potent opioid, which poses a significant risk of serious injury or infection.
Plain-English summary
Healix Infusion Therapy, Inc. is recalling 50 prefilled syringes of fentanyl 1500 mcg/30 mL (50 mcg/mL). The product is a compounded drug intended for institutional or office use only and is not for resale. The specific lot number is 7088-0 with an expiration date of 07/14.
The recall was initiated because the firm received fentanyl from a supplier who recalled the product due to loose or missing fliptop vial crimps. This defect creates a lack of assurance of sterility for the drug.
The affected product was distributed in Texas and Georgia. Consumers and healthcare providers should stop using the product and contact the recalling firm for further instructions.
The recalled product
- Product
- fentaNYL 1500 mcg/30 mL (50 mcg/mL) in prefilled syringe, COMPOUNDED DRUG For Institutional or Office Use Only--Not for Resale Federal Law Prohibits Dispensing without Prescription Healix Infusion Therapy, Inc. (866) 298-4826 1075 West Park One Drive, Suite 200, Sugar…
- Manufacturer
- Healix Infusion Therapy, Inc.
- Category
- Drug — Compounded Drug
- Affected units
- 50
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot 7088-0 Exp. 07/14
Distribution
Part of a larger recall action
This product is one of 5 recalled by Healix Infusion Therapy, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 5 products in this recall →Related recalls
Same manufacturer · Healix Infusion Therapy, Inc.
See all →- SevereHealix Recalls Fentanyl Infusion Bags Due to Sterility Concerns
FDA (Drugs) · 2014-08-27
- SevereHealix Recalls Fentanyl Infusion Bags Due to Sterility Concerns
FDA (Drugs) · 2014-08-27
- SevereHealix Recalls Fentanyl Syringes Due to Sterility Concerns
FDA (Drugs) · 2014-08-27
- SevereHealix Recalls Fentanyl and Ropivacaine Infusion Bags Due to Sterility Concerns
FDA (Drugs) · 2014-08-27
- ModerateHealix Recalls Bupivacaine HCl Bags Due to Particulate Matter
FDA (Drugs) · 2014-07-16
Same hazard · sterility
See all →- SevereK.C. Pharmaceuticals Recalls Target Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- HighFentanyl Injectable Syringes Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2023-08-09
- HighFDA Recalls Fentanyl Syringes for Sterility Assurance Failure
FDA (Drugs) · 2023-08-09
- HighFentanyl Injection Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2023-10-11
- HighFDA Recalls Fentanyl Injections Due to Sterility Assurance Concerns
FDA (Drugs) · 2023-08-09
- HighFDA Recalls Fentanyl Injectable Syringes Due to Sterility Concerns
FDA (Drugs) · 2023-10-11
- SevereSCA Pharmaceuticals Recalls Fentanyl Syringes Due to Sterility Concerns
FDA (Drugs) · 2021-01-13